Comparison of careHPV and hybrid capture 2 assays for detection of high-risk human Papillomavirus DNA in cervical samples from HIV-1-infected African women.
Ngou, J; Magooa, MP; Gilham, C
; Djigma, F; Didelot, M; Kelly, H
; Yonli, A; Sawadogo, B; Lewis, DA; Delany-Moretlwe, S; +3 more...Mayaud, P
; Segondy, M; HARP Study Group and
(2013)
Comparison of careHPV and hybrid capture 2 assays for detection of high-risk human Papillomavirus DNA in cervical samples from HIV-1-infected African women.
Journal of clinical microbiology, 51 (12).
pp. 4240-4242.
ISSN 0095-1137
DOI: 10.1128/JCM.02144-13
The careHPV and HC2 assays were compared for high-risk human papillomavirus (HR-HPV) DNA detection in cervical samples from 149 HIV-1-infected African women. The HR-HPV DNA detection rates were 37.6% and 34.9% for careHPV and HC2, respectively. Agreement between the two tests was 94.6% (95% confidence interval [CI], 89.7% to 97.7%) with a kappa value of 0.88 (95% CI, 0.81 to 0.96), indicating an excellent agreement. careHPV may be considered as suitable as HC2 for cervical cancer screening among HIV-infected African women.
Item Type | Article |
---|---|
ISI | 327147100062 |
Date Deposited | 23 Oct 2013 19:05 |
Explore Further
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838057 (OA Location)
- 10.1128/JCM.02144-13 (DOI)
- 24108613 (PubMed)
ORCID: https://orcid.org/0000-0002-9477-6090
ORCID: https://orcid.org/0000-0001-5547-3807
ORCID: https://orcid.org/0000-0001-5730-947X